Testosterone injection - Lawley Pharmaceuticals
Latest Information Update: 28 Jun 2016
At a glance
- Originator Lawley Pharmaceuticals
- Class Anabolic steroids; Androstenols; Hormonal replacements; Small molecules; Testosterone congeners
- Mechanism of Action Testosterone replacements
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- No development reported Alzheimer's disease
Most Recent Events
- 28 Jun 2016 No development reported - Phase-II for Alzheimer's disease (In the elderly, Prevention) in Australia (IM) (ACTRN12613000034730)